Esther Yoon

499 total citations
24 papers, 369 citations indexed

About

Esther Yoon is a scholar working on Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health and General Health Professions. According to data from OpenAlex, Esther Yoon has authored 24 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 7 papers in Pediatrics, Perinatology and Child Health and 6 papers in General Health Professions. Recurrent topics in Esther Yoon's work include Blood Pressure and Hypertension Studies (7 papers), Pharmaceutical studies and practices (6 papers) and Asthma and respiratory diseases (4 papers). Esther Yoon is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Pharmaceutical studies and practices (6 papers) and Asthma and respiratory diseases (4 papers). Esther Yoon collaborates with scholars based in United States, United Kingdom and Japan. Esther Yoon's co-authors include Albert P. Rocchini, David Kershaw, Sarah J. Clark, Beth A. Tarini, William H. Herman, Matthew M. Davis, Joyce M. Lee, Gary L. Freed, Lisa Cohn and Frank J. Ascione and has published in prestigious journals such as PEDIATRICS, The Journal of Pediatrics and Clinical Pharmacokinetics.

In The Last Decade

Esther Yoon

23 papers receiving 359 citations

Peers

Esther Yoon
Diane M. Lanese United States
Annie Robert Belgium
Adrian Root United Kingdom
Ali Alharbi Saudi Arabia
Rüya Mutluay Türkiye
Heath R Jennings United States
Esther Yoon
Citations per year, relative to Esther Yoon Esther Yoon (= 1×) peers Francesca Venturini

Countries citing papers authored by Esther Yoon

Since Specialization
Citations

This map shows the geographic impact of Esther Yoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Yoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Yoon more than expected).

Fields of papers citing papers by Esther Yoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Yoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Yoon. The network helps show where Esther Yoon may publish in the future.

Co-authorship network of co-authors of Esther Yoon

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Yoon. A scholar is included among the top collaborators of Esther Yoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Yoon. Esther Yoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alexander, Elizabeth, Stephen A. Harrison, Marjan Hezareh, et al.. (2023). Pharmacokinetics, Safety, and Tolerability of Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Delivered Intravenously or Intramuscularly in Japanese and Caucasian Healthy Volunteers. Clinical Pharmacokinetics. 63(1). 57–68. 2 indexed citations
2.
Chow, Timothy Y., Pirouz Shamszad, Christopher Vinnard, et al.. (2023). First‐in‐human study with SAR445088: A novel selective classical complement pathway inhibitor. Clinical and Translational Science. 16(4). 673–685. 12 indexed citations
3.
Gebremariam, Acham, et al.. (2022). Biliblanket Utilization for Outpatient Treatment of Newborn Jaundice. Clinical Pediatrics. 62(7). 725–732. 1 indexed citations
4.
Fancourt, Craig, Esther Yoon, Kenichi Furihata, et al.. (2022). Pharmacokinetics, Safety, and Tolerability of Letermovir Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Subjects. Clinical Pharmacology in Drug Development. 11(8). 938–948. 8 indexed citations
5.
Hamrén, Ulrika Wählby, et al.. (2019). <p>Safety, pharmacokinetics and pharmacodynamics of the selective glucocorticoid receptor modulator AZD7594, following inhalation in healthy Japanese volunteers</p>. Drug Design Development and Therapy. Volume 13. 3845–3853. 7 indexed citations
6.
McCrea, Jacqueline B., Sreeraj Macha, Adedayo Adedoyin, et al.. (2019). Pharmacokinetic Drug‐Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil. The Journal of Clinical Pharmacology. 59(10). 1331–1339. 63 indexed citations
7.
Cohen‐Barak, Orit, Sivan Weiss, Michèle Rasamoelisolo, et al.. (2018). A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects. Cephalalgia. 38(13). 1960–1971. 39 indexed citations
8.
Cohen‐Barak, Orit, Michèle Rasamoelisolo, Kathleen Butler, et al.. (2016). Assessment of the Pharmacokinetics, Pharmacodynamics, and Safety of Single Doses of TV‐1106, a Long‐Acting Growth Hormone, in Healthy Japanese and Caucasian Subjects. Clinical Pharmacology in Drug Development. 6(4). 331–342. 9 indexed citations
9.
Yoon, Esther, Lisa Cohn, Gary L. Freed, et al.. (2014). Use of Antihypertensive Medications and Diagnostic Tests Among Privately Insured Adolescents and Young Adults With Primary Versus Secondary Hypertension. Journal of Adolescent Health. 55(1). 73–78. 10 indexed citations
10.
Yoon, Esther, Gary L. Freed, Albert P. Rocchini, et al.. (2013). Differences in Blood Pressure Monitoring for Children and Adolescents With Hypertension Among Pediatric Cardiologists and Pediatric Nephrologists. Clinical Pediatrics. 53(10). 1008–1012.
11.
Yoon, Esther, Lisa Cohn, Albert P. Rocchini, et al.. (2012). Use of Diagnostic Tests in Adolescents With Essential Hypertension. Archives of Pediatrics and Adolescent Medicine. 166(9). 857–857. 10 indexed citations
12.
Yoon, Esther, Lisa Cohn, Albert P. Rocchini, David Kershaw, & Sarah J. Clark. (2012). Clonidine Utilization Trends for Medicaid Children. Clinical Pediatrics. 51(10). 950–955. 9 indexed citations
13.
Yoon, Esther, Lisa Cohn, Albert P. Rocchini, et al.. (2011). Antihypertensive Prescribing Patterns for Adolescents With Primary Hypertension. PEDIATRICS. 129(1). e1–e8. 38 indexed citations
14.
Lee, Joyce M., et al.. (2010). Diagnosis of Diabetes using Hemoglobin A1c: Should Recommendations in Adults Be Extrapolated to Adolescents?. The Journal of Pediatrics. 158(6). 947–952.e3. 71 indexed citations
15.
Yoon, Esther, Matthew M. Davis, Albert P. Rocchini, David Kershaw, & Gary L. Freed. (2008). Medical management of children with primary hypertension by pediatric subspecialists. Pediatric Nephrology. 24(1). 147–153. 12 indexed citations
16.
Yoon, Esther, Kevin J. Dombkowski, Albert P. Rocchini, Jen-Jar Lin, & Matthew M. Davis. (2007). Off-Label Utilization of Antihypertensive Medications in Children. Ambulatory Pediatrics. 7(4). 299–303. 12 indexed citations
17.
Yoon, Esther, et al.. (2006). FDA Labeling Status of Pediatric Medications. Clinical Pediatrics. 45(1). 75–77. 9 indexed citations
18.
Cabana, Michael D., Kevin J. Dombkowski, Esther Yoon, & Sarah J. Clark. (2005). Variation in Pediatric Asthma Quality Improvement Programs by Managed Care Plans. American Journal of Medical Quality. 20(4). 204–209. 1 indexed citations
19.
Yoon, Esther, et al.. (2005). Factors Associated with Non-Attendance at Pediatric Subspecialty Asthma Clinics. Journal of Asthma. 42(7). 555–559. 29 indexed citations
20.
Cabana, Michael D., et al.. (2005). Exposure to Tobacco Smoke and Chronic Asthma Symptoms. Pediatric Asthma Allergy & Immunology. 18(4). 180–188. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026